AMD: Education is the First Step
Age-Related Macular Degeneration (AMD) is a devastating eye disease that may result in partial or complete loss of central vision. AMD affects millions of people in the US, and is the leading cause of blindness in people over age 55. If you are suffering from low macular pigment you should have a look at the MPOD test.
The Eye-QTM Intelligent AMD Risk Management Program is designed to manage a leading AMD risk factor – low macular pigment.
AMD Risk Factors:
- Family history
- Low macular pigment
- Poor dietary habits
- Smoking (past or present)
- Light eyes, light skin
- High body mass index
- Extensive sun exposure
AMD & ZeaVision’s Comprehensive Risk Management Program
The Eye-Q program proactively manages AMD risk. We at South Coast Optometry can measure, manage, monitor, and maintain a patient’s macular pigment density at a healthy level to reduce AMD risk. Eye-Q is a comprehensive patient-focused program including:
- QuantifEye® – Macular pigment optical density measurement device (MPOD)
- EyePromise® Restore – Science based, all natural supplement
The QuantifEye device is a scientifically validated and proven technology that has been utilized by EyeCare Professionals in the USA since 2006. The device measures pigment levels in the macula, the area in the back of the eye responsible for central vision. QuantifEye provides a quick, non-invasive measurement of macular pigment, and requires no dilation. The macula contains the highest number of vision cells in the eye.
ZeaVision is a pioneer in the eye supplement field and through extensive research, development, and scientific discovery, ZeaVision led the way in identifying the importance of Zeaxanthin.